Your session is about to expire
← Back to Search
Extended Release Buprenorphine for Opioid Use Disorder (EXHITENTRE Trial)
EXHITENTRE Trial Summary
This trial is testing whether a 28-day formulation of extended-release buprenorphine is more effective than usual treatment for patients with a moderate or severe opioid use disorder who are seen by an addiction consultation service and agree to start a medication for OUD.
EXHITENTRE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowEXHITENTRE Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.EXHITENTRE Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a severe alcohol or benzodiazepine addiction that can't be treated quickly.I have been on medication for opioid use disorder up to 14 days before being hospitalized.I am 18 years old or older.I have been taking a long-acting opioid, not buprenorphine, for the last three days.I am seeking hospice care for a terminal illness.My liver tests are very high or I have chronic severe liver disease.I am willing to start medication-assisted treatment, including buprenorphine.I am currently in the hospital.
- Group 1: Treatment as Usual
- Group 2: Interventional
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are there any other instances where Extended Release Buprenorphine has been studied?
"Originally, extended release buprenorphine was trialled at Shalvata Medical Health Center back in 2012. So far, there have been a total of 297 completed studies. Right now, there are 45 active trials with a significant portion of these taking place in Baltimore, Maryland."
Are patients being sought for this treatment program at the moment?
"Yes, this information is accurate. The study in question is still recruiting patients, as shown by the listing on clinicaltrials.gov. This particular trial was posted on August 9th, 2021 and was last edited on May 10th, 2022."
Could you please tell me how many facilities are testing this new treatment?
"At the moment, this study is enrolling patients that go to Massachusetts General Hospital, Johns Hopkins Bayview Medical Center, and Hennepin Healthcare Research Institute. There are also 5 other recruitment centres."
Share this study with friends
Copy Link
Messenger